Why Everyone’s Wearing a Glucose Monitor in 2026 (Even If You’re Not Diabetic)

By infohealthtechinsights@gmail.com / July 13, 2026

📈 The Wellness Trend Nobody Saw Coming

A few years ago, a continuous glucose monitor was something almost exclusively worn by people managing diabetes — a small sensor on the arm, a doctor’s prescription, a lifetime condition attached to it. In 2026, that same little sensor is just as likely to be on the arm of someone with completely normal blood sugar, tracking how their lunch, their workout, or a bad night of sleep shows up as a curve on their phone the next morning.

This shift didn’t happen by accident. In 2024, the FDA cleared the Dexcom Stelo as the first continuous glucose monitor available without a prescription, specifically for people who don’t use insulin. Abbott followed with Lingo, its own consumer-focused CGM built on the same sensor platform behind its medical-grade FreeStyle Libre line. Suddenly, a device that used to require a doctor’s visit, an insurance approval, and a diabetes diagnosis was sitting on shelves at Walmart, next to fitness trackers and protein bars.

The pitch is compelling, and it’s easy to see why it caught on so fast in wellness and biohacking circles: see exactly how your body responds to food, stress, exercise, and sleep, in real time, instead of guessing. It fits neatly into a broader cultural moment where people already track their steps, their sleep stages, and their heart rate variability, and glucose was the obvious next frontier — a number that used to be invisible, now streaming live to your phone.

But the science on whether that data actually helps a person with normal blood sugar is genuinely more mixed than the marketing suggests — and multiple endocrinologists interviewed across several major health publications have been notably blunt about that gap. This article walks through how these devices work, what’s actually backed by evidence, what doctors are saying that rarely makes it into the product marketing, and how to think about trying one yourself if you’re curious.

🔬 How These Devices Actually Work

A CGM is a small sensor, usually worn on the back of the upper arm, that measures glucose in the fluid just under your skin — not directly in your blood — roughly every five minutes, 24 hours a day. That data streams via Bluetooth to an app on your phone, building a continuous curve instead of the single-point snapshot you’d get from a traditional fingerstick test.

Because it’s measuring interstitial fluid rather than blood directly, there’s a natural lag of roughly 10–15 minutes behind your actual blood glucose, and readings can vary by 10–20 mg/dL from a fingerstick measurement taken at the same moment. Device accuracy in this category is often described using a metric called MARD (Mean Absolute Relative Difference) — lower is better, and clinical researchers generally consider anything under 10% to be a reliable foundation for trend data. For people using a CGM to manage insulin dosing, even a small gap matters enormously, which is exactly why the OTC, non-diabetic-focused devices aren’t approved for that use. For general trend-spotting — did this meal spike me more than that one — the lag and variance matter much less.

Most apps also translate the raw curve into a simplified daily score. Abbott’s Lingo, for instance, boils a day of readings down into a single number based loosely on “time in range” — generally defined as staying between about 70 and 140 mg/dL — with lower scores indicating fewer or smaller glucose spikes. These scores are a useful, digestible summary, but it’s worth remembering they’re a wellness company’s own interpretation layer, not a standardized medical metric.

📊 The Main Players in 2026

Every OTC option on the market right now is built on the same handful of underlying sensor hardware from Dexcom or Abbott — the coaching apps and platforms are really where these products differentiate from each other, not the raw sensor technology itself. CNN Underscored’s two-week head-to-head test of Stelo and Lingo found the two devices’ readings differed by roughly 3–10 mg/dL when worn simultaneously — a useful reminder that neither is measuring with lab-level precision, even against each other.

Worth noting: Signos stands out here because it’s the only platform in this category with an FDA clearance tied to a specific outcome — weight management — rather than general wellness insight. That’s a meaningfully different regulatory bar than the general “understand your metabolism” positioning most of the other apps use.

⚖️ What the Science Actually Supports (and What It Doesn’t Yet)

For people with diagnosed diabetes, CGMs have decades of solid clinical evidence behind them. For non-diabetics, the picture is genuinely less settled — and it’s worth saying that plainly, since most marketing around these devices doesn’t.

Nicole Spartano, a researcher at Boston University’s medical school, has pointed out that follow-up evidence linking glucose spikes in non-diabetics to future diabetes risk exists, but comes from a relatively small body of research so far — not the large, long-term studies that would make it a settled question. A more recent systematic review of CGM use for cardiovascular prevention in non-diabetic adults, covering research through mid-2025, found some genuinely promising signals — CGM data helped some people time exercise around their own glucose peaks and reduced post-meal glucose spikes in a handful of small studies — but the review’s own authors noted that direct evidence connecting this to actual long-term cardiovascular outcomes remains limited.

A CGM can show you real, individual patterns in how your body responds to specific meals — that part is genuinely useful. Whether reacting to those patterns measurably improves long-term health for someone who isn’t already at risk is the part the research hasn’t fully caught up to yet.

🩺 What Doctors Are Actually Saying

This is the section that tends to get left out of most CGM coverage, and it’s worth including in full, because the skepticism here is coming from specialists who treat diabetes for a living, not from general wellness skeptics.

A Harvard Health physician writing on the topic put it bluntly: companies are marketing these devices to healthy people faster than the research can keep up, meaning consumer demand — not clinical evidence — is currently driving adoption. The same piece raises a specific, counterintuitive risk: if someone interprets a normal, biologically insignificant dip in glucose as a warning sign and starts snacking more often “to be safe,” that behavior could ironically increase their long-term diabetes risk rather than reduce it.

Priyanka Majety, an endocrinologist at VCU Health, echoed a similar point — these devices can offer real, motivating feedback about diet and activity over a short period, but she was direct that doctors don’t routinely use CGMs for people without metabolic health issues, because the evidence that it actually improves outcomes for that group isn’t there yet. Multiple endocrinologists interviewed by GoodRx went further: of four specialists asked directly, none recommended CGM use for people without diabetes, citing a real risk of “information overload and potential anxiety” in otherwise healthy users who start reading meaning into every fluctuation.

Researchers at Johns Hopkins raised a related, practical problem: there’s currently no established clinical guidance for how a healthy person should actually act on their own CGM data, because virtually all of the interpretation frameworks that exist were built for people who already have diabetes. A healthy person seeing an occasional glucose spike has no real clinical reference point for whether that number means anything at all.

🧠 The Psychological Risk That Rarely Gets Mentioned

Beyond the accuracy and evidence questions, several of the doctors and researchers cited above flagged a subtler risk: the psychological effect of constantly watching a number that most people have never had visibility into before.

Normal, healthy glucose fluctuation after meals is expected and unremarkable — but on a graph, updated every five minutes, it can look alarming even when it’s completely within a healthy range. Reporting on this trend has raised specific concern about the potential for CGM feedback to nudge some users toward increasingly restrictive eating patterns, chasing a flat line that isn’t actually a meaningful health goal for someone without diabetes. That’s worth taking seriously alongside the more straightforward “does it work” question.

✅ Who Actually Stands to Benefit

• People with prediabetes or a family history of type 2 diabetes who want concrete, personalized feedback — most doctors quoted above specifically carve out this group as the clearest exception
• Anyone diagnosed with a condition linked to insulin resistance, like PCOS, looking to understand their own patterns alongside a doctor’s guidance
• People who respond well to direct feedback loops and want to run a short, structured experiment around specific dietary changes
• Athletes fine-tuning fueling and recovery timing around training sessions

These devices are a poorer fit for:

• Anyone expecting a CGM alone to diagnose or predict a future health condition with certainty
• People prone to health anxiety or disordered eating patterns, who may find constant glucose numbers more stressful than motivating
• Anyone using OTC data to make insulin dosing decisions — these devices aren’t approved or accurate enough for that
• Buyers unwilling to commit to an ongoing subscription cost most platforms require

🛠️ How to Run Your Own CGM Experiment Responsibly

If you’re still curious after weighing the evidence and the expert skepticism above, here’s a structured way to approach it that limits the downsides doctors have flagged:

1. Set a defined time window — two to four weeks is enough to spot real patterns without turning it into an indefinite habit.
2. Decide in advance what you’re testing — a specific question like “does my afternoon coffee affect my energy crash” gives the data a purpose, rather than open-ended number-watching.
3. Expect some normal spikes, and resist the urge to treat every post-meal rise as a problem to solve.
4. Cross-check anything that concerns you with a fingerstick reading or a conversation with a doctor before changing your diet significantly.
5. Watch how you feel about the data itself. If checking the app is adding stress rather than insight, that’s a legitimate reason to stop, regardless of what the numbers say.
6. Bring the data to a doctor if something looks genuinely unusual, rather than trying to self-diagnose from an app score.

💰 What This Actually Costs

• $49–$55 per sensor: Dexcom Stelo, sold individually, roughly two weeks per sensor.
• $89 per 2-week sensor: Abbott Lingo, app-based coaching included.
• $125–$300+/year: Levels’ metabolic coaching platform, layered on top of sensor costs.
• ~$179/month: Nutrisense, including access to a registered dietitian.

A reasonable starting point for most curious non-diabetics is a single Stelo or Lingo sensor — roughly a two-week experiment — before committing to an ongoing coaching subscription. None of these costs are typically covered by insurance for non-diabetics, which is itself part of why several of the doctors quoted above questioned whether the expense is justified without stronger evidence of benefit.

⚠️ Common Mistakes People Make

• Treating every glucose spike as alarming. Some rise after eating is completely normal, even in healthy metabolisms.
• Wearing it indefinitely instead of running a defined experiment. Most practical value comes from a focused two-to-four-week period testing specific changes.
• Ignoring the accuracy caveats. OTC CGMs aren’t held to the same clinical accuracy standard as prescription devices — treat the numbers as directional, not exact.
• Sleeping on the sensor arm. Compression from side-sleeping can distort overnight readings on either device.
• Restricting food based on normal fluctuations. Several endocrinologists specifically flagged this as a risk that can backfire.
• Skipping a doctor conversation when a device flags something unusual, instead of just noting it and moving on.

❓ Frequently Asked Questions